Recent News

Share
and/or

Connect with us

291 News Items found
In the Clinic
Surgeon in blue scrubs doing operation with two assisting.
Guiding Light: New Imaging Techniques Improve Head and Neck Cancer Surgeries

MSK head and neck surgeons are investigating novel imaging methods that enable them to detect and visualize cancer cells during an operation.
Announcement
Acute myeloid leukemia cells under a microscope
FDA Approves Enasidenib (Idhifa), a First-of-Its-Kind Drug, for Advanced Blood Cancer

A new treatment option for people with acute myeloid leukemia is available, and it works in an unconventional way.
In the Lab
Representative image of a dividing tumor cell showing the extrachromosomal location of duplicated BRAF genes
Giving Drugs Together — Rather than in Sequence — May Be Key to Halting Tumor Resistance

Scientists are learning how tumors develop resistance to drugs — and what can be done about it.
In the Lab
An organoid of a developing brain
Stem Cell Research Identifies Potential Drugs for Treating Zika Infection

Researchers from MSK and Weill Cornell have found that two compounds appear to fight off infection with the Zika virus.
In the Lab
A scientist looks at illustrations of chromosomes.
When Loss Is a Gain: New Tumor Suppressor Gene Identified in Follicular Lymphoma

The reason certain patients with follicular lymphoma do worse than others may come down to a missing gene.
In the Lab
Images from three different mice showing the effects of antibiotics and microbiome replacement
Bacteria versus Bacteria: Two Studies Uncover Species of Microbes That Protect against Infections in People with Cancer

Research recently published by MSK scientists suggests that the best way to fight dangerous bacteria may be with other bacteria.
Science Byte
Developmental biologist Anna-Katerina (Kat) Hadjantonakis
It Takes Two: A Pair of Proteins Coordinate to Direct Development of Embryonic Cells

MSK researchers shed light on the signals that determine the fate of embryonic cells.
In the Clinic
MSK medical oncologist Luis Diaz, Jr.
The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers

A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.
In the News
American Society of Clinical Oncology logo
#ASCO17: Post-Conference Roundup of Themes and Trends

Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.
In the Lab
Left-handed and right-handed KRas molecules
Mirror-Image Chemistry Enables New Approach for Targeting an “Undruggable” Cancer-Causing Protein

MSK chemists are focusing on developing small-molecule drugs to target KRas, an important cancer protein.